Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IGM-2644 |
Trade Name | |
Synonyms | IGM 2644|IGM2644 |
Drug Descriptions |
IGM-2644 is a bispecific IgM T cell engager that targets CD38 and CD3, potentially resulting in complement-dependent cytotoxicity against tumor cells and inhibition of tumor growth (Blood (2022) 140 (Supplement 1): 6010-6011). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IGM-2644 | IGM-2644 | 0 | 1 |